Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05697328 · ClinicalTrials.gov registry record · NA
Barotrauma in Hyperbaric Oxygen Therapy
A NA study of Barotrauma, sponsored by John Muir Health.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05697328 is a NA study of Barotrauma that is actively recruiting participants, run by John Muir Health. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05697328, a NA study of Barotrauma, is actively recruiting participants, sponsored by John Muir Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study whether the use of pseudoephedrine can help prevent middle ear trauma during HBOT. Pseudoephedrine is an approved drug that is used for temporary relief of nasal or sinus pain and pressure.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pseudoephedrine Pill
Study Locations (1)
California
- John Muir Health - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-01-31 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05697328
The ClinicalTrials.gov registry entry for NCT05697328 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is John Muir Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barotrauma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05697328 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05697328 about?
NCT05697328 is a clinical study titled "Barotrauma in Hyperbaric Oxygen Therapy". The purpose of this research is to study whether the use of pseudoephedrine can help prevent middle ear trauma during HBOT. Pseudoephedrine is an approved drug that is used for temporary relief of nasal or sinus pain and pressure.
What is the current status of trial NCT05697328?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-01-31. Estimated completion is 2026-07.
What conditions does trial NCT05697328 study?
This clinical trial studies the following conditions: Barotrauma.
What interventions are being tested in trial NCT05697328?
The interventions under investigation include: Placebo (DRUG), Pseudoephedrine Pill (DRUG).
Who is sponsoring clinical trial NCT05697328?
This trial is sponsored by John Muir Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05697328 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.